文献速递儿科与产科急症消化、代谢与肾脏急症

SARS-CoV-2感染或儿童多系统炎症综合征患儿严重胃肠道诊断的相关因素

Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome.
PubMed 文献 · JAMA Netw Open · 2021-12-01
一句话结论意大利多中心回顾性队列显示,SARS-CoV-2感染或MIS-C患儿中9.5%出现严重胃肠道表现,腹痛(aOR 34.5)和淋巴细胞减少(aOR 8.93)是最强相关因素。

该多中心回顾性队列纳入2020年2月25日至2021年1月20日意大利COVID-19注册研究中685例<18岁急性SARS-CoV-2感染或符合美国CDC MIS-C标准的患儿(91.7%为急性感染,8.3%为MIS-C)。严重胃肠道表现定义需外科会诊的急性腹症、阑尾炎、肠套叠、胰腺炎、腹腔积液或弥漫性腺肠系膜炎,发生率为9.5%(65/685),其中41.5%接受手术。胃肠道症状与住院(OR 2.64)和ICU入住(OR 3.90)风险升高相关;严重胃肠道表现与年龄5-10岁、腹痛、淋巴细胞减少及MIS-C独立相关。作者认为及时识别可能改善严重并发症的管理。

要点

  • 685例患儿中65例(9.5%)出现严重胃肠道表现,以弥漫性腺肠系膜炎(39.6%)、阑尾炎(33.5%)、腹腔积液(21.3%)为主。
  • 出现胃肠道症状的患儿住院风险升高(OR 2.64;95%CI 1.89-3.69),ICU入住风险升高(OR 3.90;95%CI 1.98-7.68)。
  • 腹痛与严重胃肠道表现强相关(aOR 34.5;95%CI 10.1-118),淋巴细胞减少aOR 8.93(95%CI 3.03-26.3),MIS-C aOR 6.28(95%CI 1.92-20.5)。
  • 5-10岁(OR 8.33;95%CI 2.62-26.5)和>10岁(OR 6.37;95%CI 2.12-19.1)较学龄前儿童严重胃肠道表现风险更高。
  • 腹泻与腺肠系膜炎(aOR 3.13;95%CI 1.08-9.12)和腹腔积液(aOR 3.22;95%CI 1.03-10.0)风险升高相关。

适用人群与场景

  • 意大利儿科初级保健或医院收治的<18岁儿童,急性SARS-CoV-2感染(鼻咽拭子实时逆转录聚合酶链反应阳性)或符合美国CDC儿童多系统炎症综合征(MIS-C)标准。
  • 研究期间为2020年2月25日至2021年1月20日。

诊断标准与关键阈值

  • 严重胃肠道表现定义:感染期间或感染后4-6周内,经医学和/或影像学诊断的急性腹症、阑尾炎(是否合并穿孔和/或腹膜炎)、肠套叠、胰腺炎、腹腔积液、需外科会诊的弥漫性腺肠系膜炎。

红旗征与不能漏的情况

  • 腹痛:与严重胃肠道表现强相关(aOR 34.5;95%CI 10.1-118)。
  • 淋巴细胞减少:与严重胃肠道表现相关(aOR 8.93;95%CI 3.03-26.3)。
  • MIS-C:与严重胃肠道表现相关(aOR 6.28;95%CI 1.92-20.5)。
  • 腹泻:与腺肠系膜炎(aOR 3.13;95%CI 1.08-9.12)或腹腔积液(aOR 3.22;95%CI 1.03-10.0)风险升高相关。

研究设计与关键结果

  • 多中心回顾性队列研究,纳入685例患儿(386例男孩[56.4%];中位年龄7.3岁[IQR 1.6-12.4]),其中628例(91.7%)为急性SARS-CoV-2感染,57例(8.3%)为MIS-C。
  • 胃肠道症状与住院风险升高相关(OR 2.64;95%CI 1.89-3.69),与ICU入住风险升高相关(OR 3.90;95%CI 1.98-7.68)。
  • 65例(9.5%)出现严重胃肠道表现:弥漫性腺肠系膜炎39.6%、阑尾炎33.5%、腹腔积液21.3%、胰腺炎6.9%、肠套叠4.6%;65例中27例(41.5%)接受手术。
  • 严重胃肠道表现与年龄相关:5-10岁OR 8.33(95%CI 2.62-26.5),>10岁OR 6.37(95%CI 2.12-19.1),均以学龄前儿童为参照。
  • 严重胃肠道表现与腹痛(aOR 34.5;95%CI 10.1-118)、淋巴细胞减少(aOR 8.93;95%CI 3.03-26.3)、MIS-C(aOR 6.28;95%CI 1.92-20.5)相关。
  • 腹泻与腺肠系膜炎(aOR 3.13;95%CI 1.08-9.12)或腹腔积液(aOR 3.22;95%CI 1.03-10.0)风险升高相关。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,及时识别可能改善严重并发症的管理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Severe gastrointestinal (GI) manifestations have been sporadically reported in children with COVID-19; however, their frequency and clinical outcome are unknown.

OBJECTIVE: To describe the clinical, radiological, and histopathologic characteristics of children with COVID-19 presenting with severe GI manifestations to identify factors associated with a severe outcome.

DESIGN, SETTING, AND PARTICIPANTS: A multicenter retrospective cohort study (February 25, 2020, to January 20, 2021) enrolled inpatient and outpatient children (aged <18 years) with acute SARS-CoV-2 infection, confirmed by positive real-time reverse-transcriptase-polymerase chain reaction on nasopharyngeal swab or fulfilling the US Centers for Disease Control and Prevention criteria for multisystem inflammatory syndrome in children (MIS-C). The study was conducted by pediatricians working in primary care or hospitals in Italy participating in the COVID-19 Registry of the Italian Society of Pediatric Infectious Diseases.

MAIN OUTCOMES AND MEASURES: The occurrence of severe GI manifestations, defined by a medical and/or radiological diagnosis of acute abdomen, appendicitis (complicated or not by perforation and/or peritonitis), intussusception, pancreatitis, abdominal fluid collection, and diffuse adenomesenteritis requiring surgical consultation, occurring during or within 4 to 6 weeks after infection with SARS-CoV-2 infection. Logistic regression was used to estimate odds ratios (ORs) with 95% CIs of factors potentially associated with severe outcomes.

RESULTS: Overall, 685 children (386 boys [56.4%]; median age, 7.3 [IQR, 1.6-12.4] years) were included. Of these children, 628 (91.7%) were diagnosed with acute SARS-CoV-2 infection and 57 (8.3%) with MIS-C. The presence of GI symptoms was associated with a higher chance of hospitalization (OR, 2.64; 95% CI, 1.89-3.69) and intensive care unit admission (OR, 3.90; 95% CI, 1.98-7.68). Overall, 65 children (9.5%) showed severe GI involvement, including disseminated adenomesenteritis (39.6%), appendicitis (33.5%), abdominal fluid collection (21.3%), pancreatitis (6.9%), or intussusception (4.6%). Twenty-seven of these 65 children (41.5%) underwent surgery. Severe GI manifestations were associated with the child's age (5-10 years: OR, 8.33; 95% CI, 2.62-26.5; >10 years: OR, 6.37; 95% CI, 2.12-19.1, compared with preschool-age), abdominal pain (adjusted OR [aOR], 34.5; 95% CI, 10.1-118), lymphopenia (aOR, 8.93; 95% CI, 3.03-26.3), or MIS-C (aOR, 6.28; 95% CI, 1.92-20.5). Diarrhea was associated with a higher chance of adenomesenteritis (aOR, 3.13; 95% CI, 1.08-9.12) or abdominal fluid collection (aOR, 3.22; 95% CI, 1.03-10.0).

CONCLUSIONS AND RELEVANCE: In this multicenter cohort study of Italian children with SARS-CoV-2 infection or MIS-C, 9.5% of the children had severe GI involvement, frequently associated with MIS-C. These findings suggest that prompt identification may improve the management of serious complications.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Lo Vecchio A, Garazzino S, Smarrazzo A, et al. Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome. JAMA Netw Open. 2021. PMID: 34928354. doi:10.1001/jamanetworkopen.2021.39974

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。